EF Hutton Initiates Coverage On Bone Biologics with Buy Rating, Announces Price Target of $2.25
EF Hutton analyst Constantine Davides initiates coverage on Bone Biologics (NASDAQ:BBLG) with a Buy rating and announces Price Target of $2.25.
Why NVIDIA, Microsoft And Amazon Shares Traded Lower; Here Are 73 Biggest Movers From Friday
Gainers
Innovative Eyewear, Inc. (NASDAQ: LUCY) climbed 61.4% to close at $2.63 on abnormally-high volume. The company released its October investor presentation yesterday.
Dow Drops Over 2%; S&P 500 Down Over 100 Points
U.S. stocks extended losses toward the end of trading, with the Dow Jones dropping more than 650 points on Friday.
12 Health Care Stocks Moving In Friday’s Intraday Session
Gainers
Inventiva (NASDAQ:IVA) shares increased by 44.0% to $5.88 during Friday's regular session. The market value of their outstanding shares is at $247.6 million.
Why Aehr Test Systems Shares Are Trading Higher By Over 19%, Here Are 51 Stocks Moving In Friday’s Mid-Day Session
Gainers
Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 108% to $3.3943 on abnormally-high volume. The company released its October investor presentation yesterday.
Nasdaq Dips Over 300 Points; Crude Oil Rises Sharply
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 300 points on Friday.
Bone Biologics Prices $5.1M Underwritten Public Offering
WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that Bone Biologics Corporation (NASDAQ:BBLG), a developer of orthobiologic products for spine
Stocks That Hit 52-Week Lows On Monday
During Monday's session, 402 companies made new 52-week lows.
